Loading clinical trials...
Loading clinical trials...
Pilot Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
Conditions
Interventions
Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.
Locations
1
France
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France
Start Date
February 12, 2021
Primary Completion Date
February 1, 2028
Completion Date
February 1, 2028
Last Updated
April 20, 2026
NCT07040891
NCT07547774
NCT06257264
NCT05491226
NCT06492759
NCT06681064
Lead Sponsor
Institut Claudius Regaud
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions